AxoGen, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Axogen, Inc. (AXGN)
Last axogen, inc. earnings: 2/24 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.axogeninc.com
Company Research
Source: Yahoo! Finance
AxoGen, Inc. Q4 2025 Earnings Call Summary - Moby Strategic Execution and Market Development Achieved a critical regulatory milestone with FDA approval of the Biologics License Application (BLA) for Avance, establishing it as the first and only approved biologic therapeutic for peripheral nerve discontinuities. Delivered 20.2% full-year revenue growth driven by double-digit expansion across all three target markets: Extremities, Oral Maxillofacial, and Breast. Reached a financial inflection point characterized by positive cash flow and improved profitability, enabling concentrated market development efforts. Strengthened the capital structure by raising $133.3 million in net proceeds and retiring the term loan facility to eliminate interest and revenue participation obligations. Expanded the commercial footprint by adding 22 sales representatives across key markets, with new hires typically reaching independence within 6 to 9 months. Secured standard of care validation
Show less
Read more
Impact Snapshot
Event Time:
AXGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXGN alerts
High impacting Axogen, Inc. news events
Weekly update
A roundup of the hottest topics
AXGN
News
- A Look At Axogen (AXGN) Valuation After Recent Share Price Pullback And BLA Expectations [Yahoo! Finance]Yahoo! Finance
- Axogen (AXGN) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Axogen targets at least 18% revenue growth in 2026 as BLA milestone strengthens market position [Seeking Alpha]Seeking Alpha
- AxoGen Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- AxoGen (NASDAQ:AXGN) had its price target raised by analysts at Citizens Jmp from $34.00 to $42.00. They now have a "market outperform" rating on the stock.MarketBeat
AXGN
Earnings
- 2/24/26 - Beat
AXGN
Sec Filings
- 2/24/26 - Form 4
- 2/24/26 - Form 10-K
- 2/24/26 - Form 8-K
- AXGN's page on the SEC website